Lingzhi TAO

Dr. Tao Lingzhi graduated from Sun Yat-sen University of Medical Sciences and Peking University Health Science Center successively, and studied in the Mayo Clinic in the United States in 2016-2017. His main research interests are Da Vinci ® robot-assisted laparoscopic minimally invasive surgery and conventional laparoscopic minimally invasive surgery for urinary system tumors.

Dr. Tao has been engaged in the clinical work of urology in well-known public 3A hospitals for more than 20 years, and has mastered the diagnosis and treatment of common diseases in urology, such as urinary tumor, calculus, benign prostatic hyperplasia and congenital urinary malformation. He is good at minimally invasive surgical treatment of urinary tumors (prostate cancer, renal cancer, bladder cancer and adrenal tumor) and urinary calculi, especially in early diagnosis, surgical treatment and comprehensive treatment of advanced prostate cancer.

Dr. Tao is currently a member of the Urology Branch of Guangdong Medical Association and a member of the Board of Directors of the Urology Branch of Shenzhen Medical Association.